| Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation NJA Webb, RL Woolley, T Lambe, E Frew, EA Brettell, EN Barsoum, ... bmj 365, 2019 | 69 | 2019 |
| Mapping the Paediatric Quality of Life Inventory (PedsQL™) generic core scales onto the Child Health Utility Index–9 Dimension (CHU-9D) score for economic evaluation in children T Lambe, E Frew, NJ Ives, RL Woolley, C Cummins, EA Brettell, ... Pharmacoeconomics 36, 451-465, 2018 | 32 | 2018 |
| Biologic drugs as analgesics for the management of osteoarthritis T Dimitroulas, T Lambe, R Klocke, GD Kitas, RV Duarte Seminars in arthritis and rheumatism 46 (6), 687-691, 2017 | 31 | 2017 |
| Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care T Lambe, P Adab, RE Jordan, A Sitch, A Enocson, K Jolly, J Marsh, ... Thorax 74 (8), 730-739, 2019 | 29 | 2019 |
| Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. NJA Webb, RL Woolley, T Lambe, E Frew, EA Brettell, EN Barsoum, ... Health Technology Assessment (Winchester, England) 23 (26), 1, 2019 | 22 | 2019 |
| Intrathecal drug delivery systems for the management of chronic noncancer pain: a systematic review of economic evaluations RV Duarte, T Lambe, JH Raphael, S Eldabe, L Andronis Pain Practice 18 (5), 666-686, 2018 | 22 | 2018 |
| Biologic drugs as analgesics for the management of low back pain and sciatica T Dimitroulas, T Lambe, JH Raphael, GD Kitas, RV Duarte Pain Medicine 20 (9), 1678-1686, 2019 | 21 | 2019 |
| A systematic review of health state utility values for thyroid cancer R Houten, N Fleeman, E Kotas, A Boland, T Lambe, R Duarte Quality of Life Research 30, 675-702, 2021 | 19 | 2021 |
| A randomized trial to compare the safety, tolerability, and effectiveness of 3 antimalarial regimens for the prevention of malaria in Nigerian patients with sickle cell disease R Olaosebikan, K Ernest, K Bojang, O Mokuolu, AM Rehman, M Affara, ... The Journal of infectious diseases 212 (4), 617-625, 2015 | 19 | 2015 |
| Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations RV Duarte, T Lambe, JH Raphael, S Eldabe, L Andronis BMJ open 6 (7), e012285, 2016 | 13 | 2016 |
| Ziconotide for the management of cancer pain: a budget impact analysis T Lambe, R Duarte, R Eldabe, S Copley, A Kansal, S Black, D Dupoiron, ... Neuromodulation: Technology at the Neural Interface 26 (6), 1226-1232, 2023 | 6 | 2023 |
| Cladribine tablets for the first-line treatment of relapsing-remitting multiple sclerosis: an evidence review group perspective of a nice single technology appraisal T Lambe, R Duarte, J Mahon, S Nevitt, J Greenhalgh, A Boland, S Beale, ... Pharmacoeconomics 37 (3), 345-357, 2019 | 5 | 2019 |
| Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot … S Scobie, S Jowett, T Lambe, S Patel, R Woolley, N Ives, C Rick, C Smith, ... Pilot and Feasibility Studies 7 (1), 154, 2021 | 4 | 2021 |
| PREDNOS Collaborative Group: Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: Phase III randomised controlled trial … NJA Webb, RL Woolley, T Lambe, E Frew, EA Brettell, EN Barsoum, ... BMJ 365, l1800, 2019 | 4 | 2019 |
| Can Beta-D-Glucan testing as part of the diagnostic pathway for invasive fungal infection reduce anti-fungal treatment costs? DO Hamilton, T Lambe, A Howard, P Crossey, J Hughes, R Duarte, ... Medical Mycology 60 (5), myac034, 2022 | 3 | 2022 |
| Case-finding and improving patient outcomes for chronic obstructive pulmonary disease in primary care: the BLISS research programme including cluster RCT P Adab, RE Jordan, D Fitzmaurice, JG Ayres, KK Cheng, BG Cooper, ... | 3 | 2021 |
| Encorafenib with binimetinib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: an evidence review group perspective of a NICE … R Houten, J Greenhalgh, J Mahon, S Nevitt, S Beale, A Boland, T Lambe, ... PharmacoEconomics-open 5, 13-22, 2021 | 3 | 2021 |
| Comment on:“Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales Onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic … E Frew, T Lambe Pharmacoeconomics 36 (8), 1029-1029, 2018 | 2 | 2018 |
| Work package 3: chronic obstructive pulmonary disease and occupational performance P Adab, RE Jordan, D Fitzmaurice, JG Ayres, KK Cheng, BG Cooper, ... Case-finding and improving patient outcomes for chronic obstructive …, 2021 | | 2021 |
| Work package 2: the Birmingham primary care chronic obstructive pulmonary disease cohort P Adab, RE Jordan, D Fitzmaurice, JG Ayres, KK Cheng, BG Cooper, ... Case-finding and improving patient outcomes for chronic obstructive …, 2021 | | 2021 |
